Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid TumoursNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung cancer, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 12026-04-03NCT05752552

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
DeuterOncology1

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Antoine LacassagneNiceFrance60
Centre Hospitalier Universitaire de RennesRennesFrance8
Centre Léon BérardLyonFrance71
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)RotterdamNetherlands1
Hôpitaux Universitaires de Marseille TimoneMarseilleFrance3
Institut BergonieBordeauxFrance26
Institut Cœur Poumon - CHU LilleLilleFrance1
Institut Gustave RoussyVillejuifFrance58
Institut Roi Albert II - UC LouvainBrusselsBelgium1
Radboud UMCNijmegenNetherlands25
Universitair Ziekenhuis GentGhentBelgium112
UZ LeuvenLeuvenBelgium82
UZAEdegemBelgium3